car-t therapy for high-risk mcl patients
Published 2 years ago • 76 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:59
prognostic markers in mcl and the value of car-t therapy in treating high-risk disease
-
6:46
an overview of car t-cell therapies in the treatment of patients with mcl
-
3:42
an overview of car-t therapy in dlbcl and mcl
-
1:56
the potential of car-t therapy in mcl
-
2:43
car-nk and car-t for mcl
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
3:54
the latest developments in car-t and bite therapies for b-cell and mantle cell lymphoma
-
1:40
future directions for car t-cell therapy in mcl
-
2:41
managing the toxicities and increased infection risk for patients receiving car-t
-
1:06
exploring the role of car-t therapy in mcl & impact of prior treatment with btki or bendamustine
-
1:59
a potential role for car-t therapy in patients with high-risk cll
-
1:35
key mechanisms of resistance to car t-cell therapy
-
3:01
updates on the use of car-t therapy in mantle cell lymphoma and follicular lymphoma
-
3:10
universal car-t therapy for t-all
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
2:10
optimizing car-t therapy in lbcl
-
5:17
optimizing car-t therapy
-
1:08
car-t therapy: treatment burden and costs
-
4:10
car t-cell therapy for all